Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
miR-29ab1 Deficiency Identifies a Negative Feedback Loop Controlling Th1 Bias That Is Dysregulated in Multiple Sclerosis.
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
FTY720 (Fingolimod) attenuates basal and sphingosine 1-phosphate-evoked thyroid cancer cell invasion.
Pilates exercise training vs. physical therapy for improving walking and balance in people with multiple sclerosis: A randomized controlled trial.
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis.
Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies.
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.
Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease.
Fingolimod induces neuroprotective factors in human astrocytes.
Introducing demographic corrections for the 10/36 Spatial Recall Test.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Regional anesthesia in patients with pre-existing neurologic disease.
Factors affecting anxiety in multiple sclerosis.
Impact of multiple sclerosis relapses on progression diminishes with time.
Imaging of microglia in patients with neurodegenerative disorders.
[The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis.]
The cuprizone model: regional heterogeneity of pathology.
Management of optic neuritis as a clinically first event of multiple sclerosis.
Network Analysis of Randomized Controlled Trials in Multiple Sclerosis.

Pages